Your browser is no longer supported. Please, upgrade your browser.
FLDM Fluidigm Corporation daily Stock Chart
FLDM [NASD]
Fluidigm Corporation
Index- P/E- EPS (ttm)-0.79 Insider Own0.70% Shs Outstand70.46M Perf Week1.66%
Market Cap344.54M Forward P/E- EPS next Y-0.62 Insider Trans29.47% Shs Float69.83M Perf Month104.60%
Income-55.30M PEG- EPS next Q-0.22 Inst Own92.20% Short Float2.54% Perf Quarter31.45%
Sales114.70M P/S3.00 EPS this Y34.80% Inst Trans0.99% Short Ratio1.08 Perf Half Y112.61%
Book/sh2.01 P/B2.43 EPS next Y6.90% ROA-20.00% Target Price7.20 Perf Year-59.85%
Cash/sh0.69 P/C7.10 EPS next 5Y-8.06% ROE-35.10% 52W Range1.17 - 14.30 Perf YTD40.52%
Dividend- P/FCF- EPS past 5Y12.60% ROI-29.90% 52W High-65.79% Beta1.76
Dividend %- Quick Ratio1.90 Sales past 5Y0.10% Gross Margin55.50% 52W Low317.95% ATR0.58
Employees566 Current Ratio2.30 Sales Q/Q-8.30% Oper. Margin-48.50% RSI (14)65.27 Volatility10.17% 21.05%
OptionableYes Debt/Eq0.38 EPS Q/Q48.00% Profit Margin-48.20% Rel Volume1.03 Prev Close4.66
ShortableYes LT Debt/Eq0.38 EarningsMay 07 AMC Payout- Avg Volume1.65M Price4.89
Recom2.20 SMA2024.88% SMA5073.23% SMA20029.29% Volume1,689,578 Change4.82%
Nov-06-19Downgrade Janney Buy → Neutral
Oct-18-19Upgrade UBS Neutral → Buy $14 → $7
Mar-15-19Initiated UBS Neutral $14
Jan-03-19Upgrade Janney Neutral → Buy
Nov-02-18Upgrade Piper Jaffray Neutral → Overweight
Aug-05-16Reiterated Mizuho Buy $11 → $12
Aug-05-16Reiterated Cantor Fitzgerald Buy $13 → $11
May-05-16Reiterated Mizuho Buy $8 → $11
Apr-12-16Reiterated Leerink Partners Outperform $20 → $15
Jan-07-16Initiated Deutsche Bank Buy $18
Oct-30-15Upgrade Cantor Fitzgerald Hold → Buy $15 → $12
Oct-30-15Reiterated Mizuho Neutral $15 → $8
Aug-27-15Initiated Cantor Fitzgerald Hold
Aug-07-15Reiterated Mizuho Neutral $30 → $15
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
May-08-15Reiterated Maxim Group Buy $52 → $44
May-08-15Downgrade Mizuho Buy → Neutral $50 → $30
May-06-14Reiterated Maxim Group Buy $65 → $52
Apr-23-14Upgrade Mizuho Neutral → Buy $43 → $50
Mar-21-14Reiterated Maxim Group Buy $52 → $65
May-19-20 08:30AM  University of Paris Researchers Utilize Fluidigm Mass Cytometry and Maxpar Direct Immune Profiling Assay to Identify Distinct Phenotype among Patients with Severe COVID-19 GlobeNewswire
May-13-20 04:02PM  Fluidigm to Present at Upcoming Health Care Investor Conferences GlobeNewswire
May-12-20 11:44AM  Why Fluidigm Stock Is Soaring Again Today Motley Fool
May-09-20 11:01PM  Fluidigm (FLDM) Q1 2020 Earnings Call Transcript Motley Fool
May-08-20 07:35PM  Edited Transcript of FLDM earnings conference call or presentation 7-May-20 9:30pm GMT Thomson Reuters StreetEvents
May-07-20 04:05PM  Fluidigm Announces First Quarter 2020 Financial Results GlobeNewswire +18.68%
04:03PM  Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services GlobeNewswire
11:30AM  Is Fluidigm (FLDM) Outperforming Other Medical Stocks This Year? Zacks
Apr-23-20 08:30AM  OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing Fluidigm Technology GlobeNewswire +10.65%
Apr-20-20 04:06PM  Fluidigm Announces Conference Call and Webcast of First Quarter 2020 Financial Results GlobeNewswire
Apr-14-20 04:05PM  Fluidigm Provides Update on COVID-19 Impact and Preliminary Revenue Estimate for First Quarter 2020 GlobeNewswire
Apr-08-20 09:44AM  Snap Up These 5 Stocks With Rising P/E Zacks +7.03%
Apr-02-20 08:30AM  Fluidigm CyTOF Technology Used to Evaluate Stem Cell Therapy as a Potential Treatment for COVID-19 Pneumonia GlobeNewswire -7.59%
Mar-16-20 08:30AM  Consortium of Medical Schools Led by Mount Sinai Fast-Tracking COVID-19 Detection Test Utilizing Fluidigm Microfluidics Technology GlobeNewswire -12.13%
Mar-13-20 08:05AM  The Independent Director of Fluidigm Corporation (NASDAQ:FLDM), Nicolas Barthelemy, Just Bought 160% More Shares Simply Wall St. +11.02%
Mar-11-20 08:30AM  Fluidigm and SIgN Establish the First Center of Excellence in Singapore to Advance Imaging Mass Cytometry GlobeNewswire -9.00%
Mar-10-20 08:30AM  Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research GlobeNewswire +5.86%
Mar-03-20 08:00AM  Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing GlobeNewswire
Feb-26-20 08:30AM  Fluidigm Completes Acquisition of InstruNor AS GlobeNewswire -6.16%
Feb-13-20 08:10AM  Fluidigm Corporation Just Reported Earnings, And Analysts Cut Their Target Price Simply Wall St.
Feb-12-20 04:05PM  Fluidigm to Participate in Upcoming Investor Conferences GlobeNewswire -8.20%
07:46AM  Edited Transcript of FLDM earnings conference call or presentation 10-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-10-20 06:35PM  Fluidigm (FLDM) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:05PM  Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
04:02PM  Fluidigm Establishes Center of Excellence at NCI-Designated Comprehensive Cancer Center to Advance Imaging Mass Cytometry GlobeNewswire
03:00PM  Fluidigm Corp. to Host Earnings Call ACCESSWIRE
08:00AM  Fluidigm CyTOF Technology Selected by Covance to Develop Highly Multiplexed Human Immune Profiling Services GlobeNewswire
Feb-03-20 12:30PM  Earnings Preview: Fluidigm (FLDM) Q4 Earnings Expected to Decline Zacks
Jan-30-20 07:28AM  Those Who Purchased Fluidigm (NASDAQ:FLDM) Shares Five Years Ago Have A 90% Loss To Show For It Simply Wall St.
Jan-20-20 11:32AM  Landmark Nature Publication Demonstrates the Power of the Fluidigm Hyperion Imaging System to Identify Novel Cellular Signatures That Correlate with Distinct Clinical Outcomes GlobeNewswire
Jan-14-20 08:30AM  Fluidigm Provides Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019 GlobeNewswire +12.43%
Jan-13-20 08:30AM  MOgene Selects Fluidigm Advanta Assays and Juno System to Expand Its NGS Services Portfolio GlobeNewswire
Dec-18-19 08:30AM  The University of Michigan Protein Assembly Lab Selects Hyperion Imaging System for Research In Cancer Immunotherapy and Immune Phenotyping GlobeNewswire +5.78%
Dec-16-19 07:12AM  Is Fluidigm (NASDAQ:FLDM) Using Debt In A Risky Way? Simply Wall St.
Dec-12-19 08:30AM  Fluidigm Named to Greater Toronto's Top Employers for 2020 GlobeNewswire
Dec-10-19 08:30AM  Fluidigm Expands Maxpar Antibody Portfolio for High-Multiplex Tissue Imaging GlobeNewswire
Dec-09-19 08:30AM  Fluidigm Receives Life Science Industry Award for the Maxpar Direct Immune Profiling System GlobeNewswire +7.84%
Dec-08-19 04:22PM  Hedge Funds Have Never Been This Bullish On Fluidigm Corporation (FLDM) Insider Monkey
Nov-20-19 11:21AM  Fluidigm Corporation Announces Pricing of Private Offering of $50 Million of 5.25% Convertible Senior Notes GlobeNewswire
06:36AM  Fluidigm Corporation Announces Proposed Private Offering of $45 Million of Convertible Senior Notes GlobeNewswire
Nov-13-19 04:05PM  Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire +5.49%
Nov-10-19 03:29PM  Analysts See 2 Falling Knives Bouncing Back GuruFocus.com
Nov-07-19 05:37PM  Edited Transcript of FLDM earnings conference call or presentation 5-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-05-19 07:55PM  Fluidigm (FLDM) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:05PM  Fluidigm Announces Third Quarter 2019 Financial Results GlobeNewswire
04:02PM  Fluidigm Drives a New Standard in Human Immune Profiling GlobeNewswire
Nov-01-19 08:17AM  Estimating The Fair Value Of Fluidigm Corporation (NASDAQ:FLDM) Simply Wall St.
Oct-29-19 10:33AM  Fluidigm (FLDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-28-19 08:23PM  Fluidigm Corporation (FLDM) Is Burning These Hedge Funds Insider Monkey
Oct-15-19 04:15PM  Fluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) Meeting GlobeNewswire
Oct-10-19 04:10PM  Fluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results GlobeNewswire
Sep-26-19 09:16AM  Does Fluidigm Corporation's (NASDAQ:FLDM) CEO Salary Compare Well With Others? Simply Wall St. -5.02%
Sep-24-19 08:30AM  Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody Labels GlobeNewswire -6.47%
Sep-18-19 08:30AM  CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO) GlobeNewswire
Sep-10-19 07:30AM  Fluidigm Files Patent Infringement Suit Against IONpath GlobeNewswire
Sep-09-19 08:30AM  Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation GlobeNewswire
Sep-04-19 08:30AM  Fluidigm Launches Imaging Mass Cytometry Immuno-Oncology Panel Kits and Advanced CyTOF Software at the 2019 World Molecular Imaging Congress (WMIC) GlobeNewswire
Aug-27-19 08:30AM  Fluidigm and the Icahn School of Medicine at Mount Sinai Collaborate on Landmark Single-Cell Study of the Human Epigenome GlobeNewswire
Aug-21-19 07:48AM  Have Insiders Been Buying Fluidigm Corporation (NASDAQ:FLDM) Shares This Year? Simply Wall St.
Aug-20-19 04:05PM  Fluidigm to Participate in Upcoming Health Care Investor Conferences GlobeNewswire
Aug-05-19 05:44PM  Edited Transcript of FLDM earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents -14.41%
04:10PM  Fluidigm is Running in Place, but Expects to Break Out in 2020 Motley Fool
Aug-02-19 01:15PM  Here's Why Fluidigm Is Getting Crushed Today Motley Fool -33.74%
09:24AM  Fluidigm (FLDM) Q2 2019 Earnings Call Transcript Motley Fool
12:41AM  CORRECTING and REPLACING - Fluidigm Announces Second Quarter 2019 Financial Results GlobeNewswire
Aug-01-19 04:05PM  Fluidigm Announces Second Quarter 2019 Financial Results GlobeNewswire
04:01PM  Jonathan Day Named VP, Commercial Operations, Americas GlobeNewswire
08:30AM  Fluidigm to Automate RNA Sequencing Library Preparation Using Microfluidics Technology GlobeNewswire
Jul-30-19 08:30AM  Fluidigm Announces 3rd Annual Imaging Mass Cytometry User Group Meeting GlobeNewswire
Jul-25-19 10:33AM  Fluidigm (FLDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
08:30AM  Bill W. Colston Named to Fluidigm Board of Directors GlobeNewswire
Jul-08-19 07:45AM  Update: Fluidigm (NASDAQ:FLDM) Stock Gained 90% In The Last Year Simply Wall St.
Jul-03-19 01:05PM  Fluidigm Announces Conference Call and Webcast of Second Quarter 2019 Financial Results GlobeNewswire
Jun-20-19 08:30AM  Fluidigm Highlights New Advancements in Deep Cellular Profiling from Circulation to Tissue at CYTO 2019 GlobeNewswire
Jun-19-19 08:30AM  Fluidigm Introduces Three Imaging Mass Cytometry Panel Kits and Advanced CyTOF Software to Accelerate Immuno-Oncology Research GlobeNewswire
Jun-17-19 08:30AM  Fluidigm Scales Highly Multiplexed Cell Analysis with Introduction of Seven New Metal Markers GlobeNewswire
Jun-04-19 08:30AM  Oncology Researcher Andrew Quong Joins Fluidigm as Chief Science Officer GlobeNewswire
May-31-19 05:37PM  Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-29-19 08:45AM  Fluidigm Introduces Advanta RNA Fusions NGS Library Prep Assay to Accelerate Translational and Clinical Cancer Research GlobeNewswire
08:30AM  Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology GlobeNewswire
May-12-19 09:47PM  Hedge Funds Have Never Been This Bullish On Fluidigm Corporation (FLDM) Insider Monkey
May-10-19 04:05PM  Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-09-19 08:30AM  Fluidigm to Participate in Upcoming Health Care Investor Conferences GlobeNewswire
May-06-19 08:00PM  Fluidigm Delivers Growth Where It Matters Most in Q1 2019 Motley Fool
07:09AM  Edited Transcript of FLDM earnings conference call or presentation 2-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-04-19 09:15AM  Stocks Soar on Strong Jobs Report; NASDAQ at New High Zacks
May-03-19 02:38PM  Here's Why Fluidigm Shares Fell as Much as 14.4% Today Motley Fool -13.15%
01:24AM  Fluidigm (FLDM) Q1 2019 Earnings Call Transcript Motley Fool
May-02-19 08:35PM  Fluidigm (FLDM) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:25PM  Fluidigm: 1Q Earnings Snapshot Associated Press
04:05PM  Fluidigm Announces First Quarter 2019 Financial Results GlobeNewswire
04:02PM  Leading Cancer Center in Japan Selects Hyperion Imaging System to Expand Immuno-Oncology Research Studies in Colorectal Cancer GlobeNewswire
May-01-19 10:26AM  Masimo Gets CE Mark for ANI Module, Enhances Root Platform Zacks
Apr-30-19 09:00AM  Fluidigm Announces 8th Annual Mass Cytometry Summit GlobeNewswire
Apr-29-19 09:41AM  Can Mass Cytometry Drive Fluidigm's (FLDM) Q1 Earnings? Zacks
Apr-25-19 10:34AM  Fluidigm (FLDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-23-19 06:00AM  What to Watch When Fluidigm Reports Q1 Earnings Motley Fool
Apr-08-19 03:55PM  How Should Investors Feel About Fluidigm Corporation's (NASDAQ:FLDM) CEO Pay? Simply Wall St.
02:49PM  3 Stocks to Hold for the Next 20 Years Motley Fool
Apr-05-19 09:40AM  Here's Why You Should Invest in DENTSPLY (XRAY) Stock Now Zacks
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow., as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. It sells instruments, consumables, and services to academic institutions, clinical research laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. Fluidigm Corporation sells its products to academic institutions, life sciences, and clinical research laboratories that conduct research, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Linthwaite Stephen ChristopherPresident & CEOMay 20Option Exercise0.0019,4440216,037May 22 06:29 PM
JOG VIKRAMChief Financial OfficerMay 20Option Exercise0.006,650059,412May 22 06:29 PM
Kreger Bradley AllenSVP, Global OperationsMay 20Option Exercise0.005,361024,762May 22 06:28 PM
McCracken ColinChief Commercial OfficerMay 20Option Exercise0.0016,516022,023May 22 06:29 PM
Paya Carlos VDirectorMar 23Option Exercise0.002,500043,343Mar 25 05:25 PM
BARTHELEMY NICOLASDirectorMar 23Option Exercise0.002,5000151,873Mar 25 05:25 PM
COLELLA SAMUEL DDirectorMar 11Buy2.6510,00026,545161,109Mar 12 09:28 PM
COLELLA SAMUEL DDirectorMar 10Buy2.7710,00027,738151,109Mar 12 09:28 PM
BARTHELEMY NICOLASDirectorMar 06Buy3.0580,000243,872149,373Mar 10 06:59 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 20Option Exercise0.0013,585058,317Feb 24 07:07 PM
Linthwaite Stephen ChristopherPresident & CEOFeb 20Option Exercise0.0040,0900217,717Feb 24 05:05 PM
Khadder NicholasSee RemarksFeb 20Option Exercise0.0013,159058,022Feb 24 05:06 PM
Kreger Bradley AllenSVP, Global OperationsFeb 20Option Exercise0.0012,071024,336Feb 24 05:05 PM
BARTHELEMY NICOLASDirectorFeb 13Buy3.6412,25744,61469,373Feb 18 08:33 PM
Kreger Bradley AllenSVP, Global OperationsNov 20Option Exercise0.003,125013,346Nov 22 08:43 PM
Linthwaite Stephen ChristopherPresident & CEONov 20Option Exercise0.0012,5620183,953Nov 22 08:33 PM
Khadder NicholasSee RemarksNov 20Option Exercise0.004,901045,431Nov 22 08:30 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERNov 20Option Exercise0.004,751046,376Nov 22 08:28 PM
Levin Easterly Partners LLCPassive InvestorSep 17Sale5.40577,1973,116,8646,909,871Sep 19 04:27 PM
Levin Easterly Partners LLCPassive InvestorSep 11Sale5.5511,54564,1127,487,068Sep 13 04:22 PM
COLELLA SAMUEL DDirectorAug 27Buy5.192,00010,372119,481Aug 28 09:13 PM
Linthwaite Stephen ChristopherPresident & CEOAug 23Buy5.524,00022,077171,391Aug 27 07:58 PM
Linthwaite Stephen ChristopherPresident & CEOAug 20Option Exercise0.0012,5620173,717Aug 22 05:55 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 20Option Exercise0.004,751043,269Aug 22 05:54 PM
Kreger Bradley AllenSVP, Global OperationsAug 20Option Exercise0.003,125011,302Aug 22 05:54 PM
Khadder NicholasSee RemarksAug 20Option Exercise0.004,901042,962Aug 22 05:54 PM
Levin Easterly Partners LLCPassive InvestorAug 13Sale7.01151,0111,059,2828,271,611Aug 15 05:41 PM
COLELLA SAMUEL DDirectorAug 08Buy6.651,0006,653117,481Aug 12 04:57 PM
COLELLA SAMUEL DDirectorAug 07Buy6.861,0006,857116,481Aug 08 09:04 PM
Levin Easterly Partners LLCPassive InvestorAug 07Sale6.90129,237892,0609,840,084Aug 12 05:05 PM
COLELLA SAMUEL DDirectorAug 06Buy7.028,00056,183115,481Aug 08 09:04 PM
Levin Easterly Partners LLCPassive InvestorAug 01Sale12.251,62919,9569,969,321Aug 05 03:59 PM
Levin Easterly Partners LLCPassive InvestorJul 29Sale11.9782,585988,4609,970,950Jul 29 04:50 PM
Levin Easterly Partners LLCPassive InvestorJul 26Sale11.92195,9822,335,30210,053,535Jul 29 04:50 PM
Levin Easterly Partners LLCPassive InvestorJul 25Sale11.859,405111,48010,249,517Jul 29 04:50 PM
Levin Easterly Partners LLCPassive InvestorJul 24Sale11.7828,090330,99910,258,922Jul 24 05:01 PM
Levin Easterly Partners LLCPassive InvestorJul 23Sale11.5818,601215,41810,287,012Jul 24 05:01 PM
Levin Easterly Partners LLCPassive InvestorJul 22Sale11.5761,432710,90310,305,613Jul 24 05:01 PM
Levin Easterly Partners LLCPassive InvestorJul 19Sale11.5083,728963,12310,367,045Jul 19 04:21 PM
Levin Easterly Partners LLCPassive InvestorJul 18Sale11.50179,8532,068,30310,450,773Jul 19 04:21 PM
Levin Easterly Partners LLCPassive InvestorJul 17Sale11.32134,4871,522,17810,630,626Jul 19 04:21 PM
Levin Easterly Partners LLCPassive InvestorJul 01Sale12.3329,410362,77110,765,113Jul 02 04:35 PM
Levin Easterly Partners LLCPassive InvestorJun 28Sale12.30157,3491,935,48710,794,523Jul 02 04:35 PM
Levin Easterly Partners LLCPassive InvestorJun 25Sale12.2325,452311,38710,951,872Jun 27 06:04 PM
Levin Easterly Partners LLCPassive InvestorJun 24Sale12.29191,6962,355,27310,976,694Jun 27 06:04 PM
COLELLA SAMUEL DDirectorJun 20Option Exercise6.1323,600144,762107,481Jun 24 09:14 PM
BARTHELEMY NICOLASDirectorJun 17Sale12.435,10063,39841,849Jun 19 04:36 PM